Who we are
As a family-held company, we are cognisant of how work shapes who we are and who we aspire to become.
We want to change the way iron deficiency is prevented and treated.
More than one billion people around the world live with iron deficiency anaemia, making this one of the largest global health challenges of our time. At Pharmacosmos, we want to change the way iron deficiency is prevented and treated in humans and animals. We do so by striving to stay at the scientific forefront and by partnering with pioneers in scientific communities. We seek to enhance patient safety and recovery while simplifying treatment management. Our innovative principle is to help healthcare professionals, patients and society to achieve more by having to do less.
A global pioneer in carbohydrate chemistry and a leader in the development of innovative treatments for patients suffering from iron deficiency and iron deficiency anaemia.
Our global presence is strong, thanks to our skilled colleagues and partners in all the major pharmaceutical markets. Today, we are represented in more than 40 countries. This is the key to our accelerated growth and will lay the foundation for future regional and global innovation.